Diabetes attenuates psychological stress-elicited 5-HT secretion in the prefrontal cortex but not in the amygdala of mice

Brain Research

Volumn 1147, Issue 1, 2007, Pages 233-239

  Miyata, Shigeo ^a   Yamada, Naoko ^a   Hirano, Shoko ^a   Tanaka, Shun ichi ^b   Kamei, Junzo ^a  

^a HOSHI UNIVERSITY   (Japan)

^b INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE   (Japan)

Author keywords

5 HT; Amygdala; Diabetes; Microdialysis; Prefrontal cortex; Psychological stress

Indexed keywords

CITALOPRAM; HUMAN INSULIN; INSULIN; POTASSIUM CHLORIDE; SEROTONIN; STREPTOZOCIN;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG ACCUMULATION; FREEZING; IN VIVO STUDY; MALE; MENTAL STRESS; MICRODIALYSIS; MOUSE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; SEROTONIN RELEASE; STREPTOZOCIN DIABETES;

AMYGDALA; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; FEAR; FREEZING REACTION, CATALEPTIC; MALE; MICE; MICE, INBRED ICR; MICRODIALYSIS; PREFRONTAL CORTEX; SEROTONIN; STREPTOZOCIN; STRESS, PSYCHOLOGICAL;

MUS;

EID: 34147121045     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.02.001     Document Type: Article

References (35)

1. Anderson R.J., Freedland K.E., Clouse R.E., and Lustman P.J. The prevalence of comorbid depression in adults with diabetes. A meta-analysis. Diabetes Care 24 (2001) 1069-1078
2. Balfour D.J., and Reid A. Effects of betamethasone on the stimulation of corticosterone secretion in rats. Arch. Int. Pharmacodyn. Ther. 237 (1979) 67-74
3. Biessels G.J., Kamal A., Ramakers G.M., Urban I.J., Spruijt B.M., Erkelens D.W., and Gispen W.H. Place learning and hippocampal synaptic plasticity in streptozotocin-induced diabetic rats. Diabetes 45 (1996) 1259-1266
4. Bitar M., Koulu M., Rapoport S.I., and Linnoila M. Diabetes-induced alteration in brain monoamine metabolism in rats. J. Pharmacol. Exp. Ther. 236 (1986) 432-437
5. Broderick P.A., and Jacoby J.H. Central monoamine dysfunction in diabetes: psychotherapeutic implications: electroanalysis by voltammetry. Acta Physiol. Pharmacol. Latinoam. 39 (1989) 211-225
6. Commissiong J.W. Monoamine metabolites: their relationship and lack of relationship to monoaminergic neuronal activity. Biochem. Pharmacol. 34 (1985) 1127-1131
7. Davidson R.J. Anxiety and affective style: role of prefrontal cortex and amygdala. Biol. Psychiatry 51 (2002) 68-80
8. de Groot M., Anderson R.J., Freedland K.E., Clouse R.E., and Lustman P.J. Association of depression and diabetes complications: a meta-analysis. Psychosom. Med. 63 (2001) 619-630
9. Degroot A., Wade M., Salhoff C., Davis R.J., Tzavara E.T., and Nomikos G.G. Exposure to an elevated platform increases plasma corticosterone and hippocampal acetylcholine in the rat: reversal by chlordiazepoxide. Eur. J. Pharmacol. 493 (2004) 103-109
10. Dilts R.P., and Boadle-Biber M.C. Differential activation of the 5-hydroxytryptamine-containing neurons of the midbrain raphe of the rat in response to randomly presented inescapable sound. Neurosci Lett. 199 (1995) 78-80
11. Grigsby A.B., Anderson R.J., Freedland K.E., Clouse R.E., and Lustman P.J. Prevalence of anxiety in adults with diabetes: a systematic review. J. Psychosom. Res. 53 (2002) 1053-1060
12. Hashimoto S., Inoue T., and Koyama T. Effects of conditioned fear stress on serotonin neurotransmission and freezing behavior in rats. Eur. J. Pharmacol. 378 (1999) 23-30
13. Hilakivi-Clarke L.A., Wozniak K.M., Durcan M.J., and Linnoila M. Behavior of streptozotocin-diabetic mice in tests of exploration, locomotion, anxiety, depression and aggression. Physiol. Behav. 48 (1990) 429-433
14. Juszkiewicz M. The effect of insulin on the central serotonergic system of the rat. Pol. J. Pharmacol. Pharm. 37 (1985) 591-600
15. Kamei J., and Saitoh A. Evidence for the modulation of spontaneous locomotor activity by higher serum glucose levels and/or spleen-derived factor(s) in diabetic mice. Life Sci. 60 (1997) 1699-1708
16. Kamei J., Ohsawa M., Tsuji M., Takeda H., and Matsumiya T. Modification of the effects of benzodiazepines on the exploratory behaviors of mice on a hole-board by diabetes. Jpn. J. Pharmacol. 86 (2001) 47-54
17. Kamei J., Miyata S., Morita K., Saitoh A., and Takeda H. Effects of selective serotonin reuptake inhibitors on immobility time in the tail suspension test in streptozotocin-induced diabetic mice. Pharmacol. Biochem. Behav. 75 (2003) 247-254
18. 14C] streptozotocin and its distribution and excretion in the rat. Biochem. J. 142 (1974) 673-683
19. Koolhaas J.M., Korte S.M., De Boer S.F., Van Der Vegt B.J., Van Reenen C.G., Hopster H., De Jong I.C., Ruis M.A., and Blokhuis H.J. Coping styles in animals: current status in behavior and stress-physiology. Neurosci. Biobehav. Rev. 23 (1999) 925-935
20. Lernmark B., Persson B., Fisher L., and Rydelius PA. Symptoms of depression are important to psychological adaptation and metabolic control in children with diabetes mellitus. Diabet. Med. 16 (1999) 14-22
21. Lustman P.J., Anderson R.J., Freedland K.E., de Groot M., Carney R.M., and Clouse R.E. Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care 23 (2000) 934-942
22. Magarinos A.M., and McEwen B.S. Experimental diabetes in rats causes hippocampal dendritic and synaptic reorganization and increased glucocorticoid reactivity to stress. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 11056-11061
23. Manjarrez G., Herrera R., Leon M., and Hernandez-R J. A low brain serotonergic neurotransmission in children with type 1 diabetes detected through the intensity dependence of auditory-evoked potentials. Diabetes Care 29 (2006) 73-77
24. Mazze R.S., Lucido D., and Shamoon H. Psychological and social correlates of glycemic control. Diabetes Care 7 (1984) 360-366
25. 1A receptor in the mouse tail suspension test. Neuropsychopharmacology 29 (2004) 461-469
26. Musselman D.L., Betan E., Larsen H., and Phillips L.S. Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment. Biol. Psychiatry 54 (2003) 317-329
27. Paxinos G., and Franklin K.B.J. The Mouse Brain in Stereotaxic Coordinates (2001), Academic Press, San Diego
28. Rowland N.E., and Bellush L.L. Diabetes mellitus: stress, neurochemistry and behavior. Neurosci. Biobehav. Rev. 13 (1989) 199-206
29. Schein P.S. 1-Methyl-1-nitrosourea depression of brain nicotinamide adenine dinucleotide in the production of neurologic toxicity. Proc. Soc. Exp. Biol. Med. 131 (1969) 517-520
30. Shimizu H. Alteration in hypothalamic monoamine metabolism of freely moving diabetic rat. Neurosci. Lett. 131 (1991) 225-227
31. Stanford S.C. 5-Hydroxytryptamine. In: Webster R.A. (Ed). Neurotransmitters, Drugs and Brain Function (2001), John Wiley & Sons Ltd., England 187-209
32. Tarui S., Yamada K., and Hanafusa T. Animal models utilized in the research of diabetes mellitus - with special reference in insulitis-associated diabetes. Prog. Clin. Biol. Res. 229 (1987) 211-223
33. Thorre K., Chaouloff F., Sarre S., Meeusen R., Ebinger G., and Michotte Y. Differential effects of restraint stress on hippocampal 5-HT metabolism and extracellular levels of 5-HT in streptozotocin-diabetic rats. Brain Res. 772 (1997) 209-216
34. Vahabzadeh A., Boutelle M.G., and Fillenz M. Effects of changes in rat brain glucose on serotonergic and noradrenergic neurons. Eur. J. Neurosci. 7 (1995) 175-179
35. Yamato T., Misumi Y., Yamasaki S., Kino M., and Aomine M. Diabetes mellitus decreases hippocampal release of neurotransmitters: an in vivo microdialysis study of awake, freely moving rats. Diabetes Nutr. Metab. 17 (2004) 128-136